Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Platelet antithrombin deficiency: a new clinical entity.

J L Tullis, K Watanabe

    The American Journal of Medicine
    |September 1, 1978
    PubMed
    Summary
    This summary is machine-generated.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Human necrobacillosis; with report of death in a sailor.

    American journal of clinical pathology·2010
    Same author

    Ischemic muscle damage.

    United States naval medical bulletin·2010
    Same author

    Injuries produced by the atomic bomb; observations on animals exposed at Bikini.

    The American journal of pathology·2010
    Same author

    The pathologic changes induced by ionizing radiations in the Bikini animals.

    The American journal of pathology·2010
    Same author

    Gross autopsy observations in the animals exposed at Bikini; a preliminary report.

    Journal of the American Medical Association·2010
    Same author

    Effects of experimental hypertonia on circulating leukocytes.

    The Journal of clinical investigation·2010

    Familial hypercoagulability may stem from platelet antithrombin deficiency, not just serum antithrombin III levels. This suggests a novel cause for blood clotting disorders in some families.

    Area of Science:

    • Hematology
    • Coagulation Science
    • Genetics

    Background:

    • Investigated a family with a history of multiple thromboses to identify underlying coagulant abnormalities.
    • Assessed serum antithrombin III levels and platelet antithrombin activity in 13 family members.

    Observation:

    • Serum antithrombin III deficiency was identified in approximately half of the family members.
    • Platelet antithrombin deficiency was found in 10 out of 13 individuals.
    • A clear correlation between serum antithrombin III deficiency and thrombosis history was absent.

    Findings:

    • A significant association was observed between platelet antithrombin deficiency and the absence of thrombosis history.
    • Hypothesized that platelet antithrombin deficiency could be a primary cause of familial hypercoagulability.

    Related Experiment Videos

  • Suggested that serum antithrombin III deficiency might be a secondary effect in some cases.

    • Implications:

    • Highlights the potential role of platelet antithrombin in familial thrombotic disorders.
    • Revises understanding of hypercoagulability causes, differentiating primary platelet vs. secondary serum deficiencies.
    • Opens avenues for targeted diagnostic and therapeutic strategies for thrombophilia.